A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis

NCT03224351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: VX-659
DRUG: TEZ/IVA
DRUG: IVA
DRUG: Placebo (matched to VX-659/TEZ/IVA)
DRUG: TEZ
DRUG: VX-561
DRUG: Placebo (matched to VX-659/TEZ/VX-561)

Sponsor

Vertex Pharmaceuticals Incorporated